Chatalic et al. showed that coinjection of PMPA with 111In/177Lu-PSMA I&T could improve the tumor-to-kidney absorbed dose ratio, but this improvement was accompanied by a reduction in tumor uptake (7). The gene discussed is FOLH1; the disease is neoplasm.